Groups

 Blood ( µg/ml)

Liver ( µg/gm tissue)

Kidney ( µg/gm tissue)

Brain ( µg/gm tissue)

Control group

0.15  ±  0.011

0.68  ±  0.13

0.12  ±  0.01

ND

Cd exposed group

11.79  ±  2.4***

16.87 ±  1.17***

13.49 ± 2.21***

3.89 ± 0.27

Ceftriaxone plus sulbactam with VRP1034 treated group

6.75 ±  0.89***

10.11 ±  0.83***

9.55 ±  1.07***

0.62 ±  0.12***
All data are Mean ± SD of each group. Newman keuls test was performed for statistical significance between control group vs Cd exposed group and Cd exposed group vs ceftriaxone plus sulbactam with VRP1034 treated group. Where ***p<0.001(highly significant) **p<0.01(significant); *p<0.05(significant) Nsp>0.05 (non significant).
Table 7: Effect of ceftriaxone plus sulbactam with VRP1034 on cadmium level in blood and tissues after 21 days treatment.